Fundamentun, LLC Merck & Co., Inc. Transaction History

Fundamentun, LLC

$1.34 Billion
Q3 2024

A detailed history of Fundamentun, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fundamentun, LLC holds 80,481 shares of MRK stock, worth $7.84 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

80,481

Previous 55,119 46.01%

Holding current value

$7.84 Million

Previous $6.82 Million 33.94%

% of portfolio

0.68%

Previous 0.61%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$111.15 - $128.97 $2.82 Million - $3.27 Million	25,362 Added 46.01%	80,481 $9.14 Million
Q2 2024 Jul 24, 2024	BUY	$123.8 - $132.96 $2.1 Million - $2.26 Million	16,999 Added 44.59%	55,119 $6.82 Million
Q1 2024 Apr 16, 2024	BUY	$113.24 - $131.95 $2.17 Million - $2.52 Million	19,126 Added 100.69%	38,120 $5.03 Million
Q4 2023 Jan 24, 2024	BUY	$100.18 - $109.02 $4,708 - $5,123	47 Added 0.25%	18,994 $2.07 Million
Q3 2023 Oct 24, 2023	BUY	$102.95 - $114.33 $113,245 - $125,763	1,100 Added 6.16%	18,947 $1.95 Million
Q2 2023 Jul 18, 2023	BUY	$108.61 - $118.38 $202,883 - $221,133	1,868 Added 11.69%	17,847 $2.06 Million
Q1 2023 May 01, 2023	BUY	$102.94 - $114.86 $978,856 - $1.09 Million	9,509 Added 146.97%	15,979 $1.7 Million
Q4 2022 Jan 19, 2023	SELL	$87.44 - $112.11 $16,263 - $20,852	-186 Reduced 2.79%	6,470 $0
Q3 2022 Oct 24, 2022	BUY	$84.53 - $94.96 $248,433 - $279,087	2,939 Added 79.07%	6,656 $573,000
Q2 2022 Sep 06, 2022	BUY	$83.49 - $94.64 $18,618 - $21,104	223 Added 6.38%	3,717 $339,000
Q1 2022 Apr 26, 2022	BUY	$73.51 - $82.4 $14,040 - $15,738	191 Added 5.78%	3,494 $287,000
Q4 2021 Jan 14, 2022	SELL	$72.28 - $90.54 $346,727 - $434,320	-4,797 Reduced 59.22%	3,303 $253,000
Q3 2021 Oct 19, 2021	SELL	$71.68 - $78.83 $2.45 Million - $2.69 Million	-34,153 Reduced 80.83%	8,100 $608,000
Q2 2021 Jul 19, 2021	SELL	$70.31 - $77.77 $191,032 - $211,301	-2,717 Reduced 6.04%	42,253 $3.29 Million
Q1 2021 Apr 27, 2021	SELL	$68.86 - $81.11 $155,967 - $183,714	-2,265 Reduced 4.8%	44,970 $3.47 Million
Q4 2020 Jan 29, 2021	BUY	$71.77 - $79.65 $627,485 - $696,379	8,743 Added 22.71%	47,235 $3.86 Million
Q3 2020 Oct 29, 2020	BUY	$73.18 - $82.95 $376,877 - $427,192	5,150 Added 15.45%	38,492 $3.19 Million
Q2 2020 Jul 28, 2020	BUY	$70.42 - $80.13 $426,463 - $485,267	6,056 Added 22.19%	33,342 $2.58 Million
Q1 2020 May 04, 2020	BUY	$63.36 - $87.82 $755,694 - $1.05 Million	11,927 Added 77.65%	27,286 $2.1 Million
Q4 2019 Jan 29, 2020	BUY	$77.58 - $87.54 $83,088 - $93,755	1,071 Added 7.5%	15,359 $1.4 Million
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $105,751 - $115,272	1,390 Added 10.78%	14,288 $1.2 Million
Q2 2019 Aug 06, 2019	BUY	$69.84 - $81.59 $125,642 - $146,780	1,799 Added 16.21%	12,898 $1.08 Million
Q1 2019 May 07, 2019	BUY	$69.58 - $79.36 $772,268 - $880,816	11,099 New	11,099 $923,000

Others Institutions Holding MRK

# of Institutions

3,819

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $247B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fundamentun, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fundamentun, LLC with notifications on news.

Account